On January 13, 2012, Palisade Capital’s Chief Investment Officer – Institutional Dennison T. Veru appeared on Fox Business News. Please click on the link below to view his appearance.

http://video.foxbusiness.com/v/1389440512001/veru-financials-are-under-owned

David Picher joined Palisade Capital in January as Managing Director, Institutional Sales and Marketing.   In this role, David will lead Palisade’s institutional sales, marketing, and client service departments, and will report to Chief Operating Officer Jeffrey Serkes.

David joins Palisade with 25 years of sales experience in investment management, including over 15 years of institutional focus.  David was most recently at Crosswind Investments, a start-up investment boutique.  Previously, David was at Pyramis Global Advisors, where he was Senior Vice President and Head of Global Consultant Relations.  In this role, David led a team that launched a new alternatives investment platform and distributed traditional and alternative asset products, primarily through investment consultants.  Prior to Pyramis, David was Managing Director of Consultant Relations and Sales at MFS Investment Management, where he sold long-only U.S. and Global equity strategies.  During his 13 year tenure at MFS, he served in various leadership and sales roles working with investment consultants and institutional plan sponsors, helping transform MFS from a primarily retail firm to a global institutional investment manager.  Prior to MFS, David spent 10 years in retail sales, including tenures at Fidelity and Merrill Lynch.

David received his B.S. in Business Administration from the University of Vermont.
 

James Boothby joined Palisade Capital in October 2011 as Vice President of Institutional Sales.  Mr. Boothby is responsible for marketing Palisade’s equity and convertible strategies to single and multi-family offices, foundations, endowments, and fund-of-funds.  Mr. Boothby reports to Jeff Serkes, Palisade's Chief Operating Officer.

Prior to joining Palisade, Mr. Boothby worked at Roosevelt Investments, where he was Vice President of the Private Client Group.  Prior to Roosevelt, Mr. Boothby was Director of Institutional Sales at Aviva Investors and Director of Marketing and Client Development at Ram Capital Resources.

Mr. Boothby received his B.A. from the University of Liverpool and holds his Financial Planning Certificates 1, 2, and 3.

Jason Schwartz joined Palisade Capital in October 2011 as Regional Vice President of Business Development.  Mr. Schwartz will manage all intermediary sales activities within the Central/Midwest region, including the development of business plans and strategies to maximize sales in the region.  Mr. Schwartz will report to Damon Gough, Palisade's Vice President of Business Development.

Prior to joining Palisade, Mr. Schwartz worked at Oppenheimer Funds where he was a regional sales representative.  Prior to Oppenheimer Funds, Jason was an External Wholesaler at ING Mutual Funds and a Senior Internal Wholesaler at Pilgrim Securities.

Jason received his B.A. in economics from Binghamton University.

Mitchell Leung joined Palisade Capital in July 2011 as Senior Vice President of Convertible Securities.  Mr. Leung’s responsibilities include security selection for both the long only and convertible arbitrage portfolios with a focus on the technology sector.  Mr. Leung reports to the Managing Director of Convertible Securities.

Prior to joining the firm, Mr. Leung worked at Twenty-First Securities where he was a derivatives trader.  In this role he was responsible for modeling, pricing and trading listed and OTC equity option strategies.  Prior to Twenty-First Securities, Mr. Leung worked at Wachovia where he was a senior proprietary trader in convertible securities.

Mr. Leung received his M.B.A. in finance from Columbia Business School, his M.A. in Mathematics from Columbia University, and his B.S. with distinction from Cornell University.

Alison Berman joins Palisade Capital in May 2011 as Associate General Counsel. As a member of the Firm’s legal department, Alison will be responsible for assisting in the management and oversight of the firm's legal affairs, private equity efforts and business development. 

Alison joined Palisade from Skadden, Arps, Slate, Meagher & Flom, LLP, where she was an associate in the mergers and acquisitions group responsible for representing various corporate and private equity clients in merger and acquisition transactions, including negotiated and contested acquisitions.  Alison also advised clients on various securities law and corporate governance matters.

Alison received her Juris Doctor from the Benjamin N. Cardozo School of Law and her B.A. from Brown University. 

Michael Appleton joined Palisade Capital in March 2011, as Vice President of Compliance.  As a member of the Firm’s compliance department, Michael will strengthen Palisade’s comprehensive compliance program for the benefit of our clients.

Michael joined Palisade from Alaric Compliance Services , a compliance consulting firm,  where he was a Director responsible for on-site client consulting engagements, mock SEC compliance audits, policy and procedure reviews, internal control reviews, and compliance program design.  Prior to that, Michael worked as Chief Compliance Officer at both Dreman Value Management and Reich & Tang Asset Management.  He also worked in the compliance departments of Prudential Global Asset Management and Furman Selz.

Michael received his B.A. in economics from Rutgers University and has successfully completed his Level I Certification from the Charles River Compliance Program.

Caroline Deetjen joined Palisade Capital in August 2010 as Marketing Associate.  Caroline is responsible for initiating and updating marketing materials and databases, completing RFPs, competitive analysis, sales support, and client service.
 
Caroline joined Palisade from Aetos Capital, where she was Associate, Business Development and Client Relations, responsible for maintaining client relationships and developing marketing materials.  Caroline received her Bachelor of Science in Business Administration from Villanova University.

Jonathan A. Masarof joined Palisade Capital in June 2010, as Vice President of Risk Management & Portfolio Analysis.  Jonathan is responsible for firm-wide risk measurement and management, GIPS compliance, attribution and portfolio analytics, and performance measurement.
 
Jonathan joined Palisade from Clay Finlay where he held the position of Investment Risk and Performance Manager and was responsible for risk and performance measurement for the firm’s global equity products.  Prior to that, Jonathan worked at Brown Brothers Harriman, where he was a Quantitative Performance and Financial Analyst for their international equity group. Jonathan received his B.A. in Journalism from the University of Rhode Island.

Neurologix, Inc. (OTC Bulletin Board: NRGX), today announced positive results in a Phase 2 trial of its investigational gene therapy for advanced Parkinson's disease (PD), NLX-P101. Study participants who received NLX-P101 experienced statistically significant and clinically meaningful improvements in off-medication motor scores compared to control subjects who received sham surgery. In the trial, this benefit was seen at one month and continued virtually unchanged throughout the six month blinded study period. The results also demonstrated a positive safety profile for NLX-P101, with no serious adverse events related to the gene therapy or surgical procedure reported. Patients enrolled in the trial had moderate to advanced PD and were not adequately responsive to current therapies.

Please click here for full press release

Mr. Picchi joined Palisade Capital in July 2009 after a 30-plus-year investment career. Prior to his joining Palisade, Mr. Picchi worked as an analyst and consultant for several mid-sized broker/dealers and investment advisory firms.

From 1980 to 1999, Mr. Picchi was an All Star rated energy analyst at Salomon Brothers, Kidder Peabody, and Lehman Brothers, where he also served as Director of US Stock Research. On the institutional side of the investment business, Mr. Picchi was sole manager of the 5 star rated, $1.5 billion Capital Appreciation Fund of Federated Investors, where he served as US Director of Research from January 2000 to June 2002.

A graduate of Georgetown University's School of Foreign Service, Mr. Picchi is also a Chartered Financial Analyst. Mr. Picchi speaks frequently on energy and investment topics for Bloomberg, CNBC and the New York Society of Security Analysts.

Palisade Capital Management, the Fort Lee, NJ-based, Institutional and High Net Worth registered investment advisor with $1.7 billion under management as of December 31, 2008, announced today the acquisition of the small, smid, and mid-cap growth equity strategies of AG Asset Management, of New York, NY. The investment team, managing approximately $600 million of client assets, is joining Palisade Capital as part of the purchase transaction.

In making the announcement, Martin L. Berman, Palisade Capital Management's Chairman and Chief Executive Officer, said, 'On behalf of all the partners and employees of PCM, I welcome our new associates and clients to the Firm. The current financial climate, while challenging, is providing us with strategic opportunities for growth, and I am excited about this combination and the enhanced capability of the Firm to serve our existing and new clients.'

Dennison (Dan) T. Veru, Palisade Capital Management's Executive Vice-President and Co-CIO, noted that, 'PCM's new Growth Equity Team consists of two portfolio managers and four senior analysts, who will manage portfolios on behalf of approximately 20 clients, all but one of which are new relationships for Palisade Capital. Also joining the Firm from AGAM are their head-equity trader and their marketing professional responsible for platform sponsor distribution, which includes SMA and UMA type accounts.'

Mr. Veru continued, 'The new Growth Equity Team's investment philosophy and process closely resembles PCM's time tested methods. Because there is no product overlap, the investment team led by Sammy Oh and William Potter will continue to operate autonomously while leveraging PCM's research, core competencies and infrastructure.'

The small, smid and mid cap growth strategies will continue to be led by Managing Directors/Senior Portfolio Managers Will Potter and Sammy Oh. Allen Margolius is joining PCM as Associate Portfolio Manager and Senior Vice President of Research for the small and smid cap growth strategies and Brian Zimmerman is joining the Firm as Associate Portfolio Manager and Senior Vice President of Research for the mid cap growth strategy. Mr. Margolius and Mr. Zimmerman are also senior analysts and will be joined by Lisa Chai and Kris Tomasovic Nelson, CFA. In addition, Brian Deitelzweig is joining PCM as head of institutional trading and Damon Gough is joining PCM to lead the Firm's intermediary distribution channel.

In addition to these new full-time members of the Palisade team, John Myers, currently Chairman of AGAM, and Beth Dater, currently AGAM's Chief Investment Officer, will be joining Palisade as special advisors. Ms. Dater has a distinguished career that includes senior roles at Warburg Pincus, Credit Suisse Asset Management, Forstmann Leff and AGAM. Prior to AGAM, Mr. Myers spent more than 30 years at General Electric and was the Chief Executive Officer of GE Asset Management until the summer of 2006. His role included oversight of the GE pension fund, one of the largest in the country.

Formed in 1995, Palisade Capital Management's founding principals have worked together for over 30 years. As of December 31, 2008, the Firm's dedicated investment teams manage $1.7 billion of assets in small-cap core, convertible securities, private equity and private wealth management portfolios. PCM's clients include four of America's 20 largest corporate sponsored pension plans, with each of these clients entrusting the Firm with portfolios for at least two of the aforementioned strategies.

On September 25, 2008, Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $7.5 million in SWN Communications Inc. ('Send Word Now' or the 'Company') as part of a $14 million Series D financing round. Send Word Now is the leading Software as a Service Provider in emergency notification, on demand alerting and response services that deliver effective communication during time sensitive situations. The Company's core business provides a solution for a compelling need for emergency communication during crisis situations. In recent years such situations have involved educational institutions, terrorists, and natural disasters. Proceeds from the round will allow Send Word Now to expand its software development, infrastructure, and sales and marketing.

On September 2, 2008, Jeffrey Weekes joined Palisade Capital Management as an Associate in the Firm's Private Equity department. Mr. Weekes will be reporting to James Jahnke, Managing Director of Private Equity, and will be responsible for monitoring and analyzing private equity investment opportunities and for building and maintaining financial models for potential private equity investments and existing portfolio companies. Prior to joining Palisade, Mr. Weekes was an Investment Banking Analyst at Citigroup Global Markets, Inc. where he was responsible for analyzing and participating in the execution of mergers & acquisitions, carve-outs, and equity and debt financings for companies in the technology sector. Prior to Citigroup, Jeff was an Energy Analyst at the Center for Advanced Energy Systems. Mr. Weekes received his B.A. in Mechanical Engineering, with a minor in Economics, from Rutgers University, and a B.A. in Physics from Davidson College.

On August 25, 2008, Palisade Concentrated Equity Partnership II, LP ("PCEPII"), a $140 million private equity fund managed by Palisade Capital Management, LLC, committed to invest $3 million in Caliber Therapeutics, Inc. ("Caliber"). Caliber is a provider of a potentially game-changing drug-eluding balloon technology for vascular applications. PCEPII committed to two separate tranches and invested $1.35 million in the first tranche of the $9 million Series A financing round. These funds will be used to secure and develop intellectual property, pay joint venture development costs, and prepare for clinical studies.

On May 16, 2008, PCEPII invests $15.0 million in Glenmount Global Solutions, Inc. ('Glenmount' or the 'Company'). Glenmount is a leading independent industrial IT services firm in North America, with over 350 associates in 25 offices. Proceeds from the financing round were used primarily to acquire Crown Holdings, which will be merged with Glenmount's two other operating companies to expand the Company's reach and expertise across a variety of industries and business sectors, including water & wastewater, metals, food & beverage, and oil & gas.

Ms. Madha joined Palisade Capital on April 28, 2008. As Marketing Associate, Eva is responsible for completing RFPs and for developing, preparing, revising and maintaining marketing materials, competitive analyses and lead generation. In addition, Eva will work with consultants to ensure that information regarding Palisade in consultants' databases is kept current. Eva joins us from Bear Stearns where she was a Marketing and Data Analyst. Prior to that, Eva worked for eight years at Merrill Lynch, her last position being Request for Proposal Analyst. Eva has successfully completed Level 1 of the CFA Program. She received her Aerospace Engineering Masters from Parks College, Cahokia, IL and her B.S. in Aerospace Engineering Technology from Cal State Polytechnic, Pomona, CA.

On March 31, 2008, Jason Rich joined Palisade Capital Management as Private Equity Associate. Mr. Rich will be reporting to James Jahnke, Managing Director of Private Equity, and will be responsible for analyzing, structuring and negotiating private investments and assisting with managing the existing portfolio. Prior to joining Palisade, Mr. Rich was the Vice President of Finance and Chief Financial Officer of Regus Industries, LLC. Prior to Regus, Mr. Rich was with First Broadcasting, LLC, a private investment firm based in Dallas and TD Securities' Media & Communications Investment Banking Group in New York. Mr. Rich received a BS degree from Providence College.

On February 11, 2008, Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $6.2 million in Ruby Tequila's Mexican Kitchen, LLC ('Ruby Tequila's'). Ruby Tequila's operates four Texas Mexican style restaurants in Lubbock, Amarillo and Selma, Texas. Ruby Tequila's will use the financing to support its roll out of over 30 restaurants over the next five years. Ruby Tequila's was founded in 1991 and differentiates itself through the delivery of high quality mesquite grilled food made from scratch, good service, and a fun, vibrant atmosphere.

On February 11, 2008 Bruce Deutsch joined Palisade Capital Management in a newly created position at the firm - Managing Director of Institutional Sales and Marketing. Bruce reports to Jeffrey D. Serkes and is responsible for marketing Palisade's current and future institutional products. In addition to selling directly to corporate and municipal pension funds, Bruce will market to pension consultants, endowments, fund-of-funds, Taft-Hartley accounts and other distribution channels not historically pursued by Palisade. Mr. Deutsch joins Palisade from Atalanta Sosnoff Capital, LLC, where he was responsible for establishing institutional consulting and plan sponsor relationships. Bruce received his Bachelor of Science in Accounting from Lehigh University.

On December 28, 2007, Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $8.1 million in Shoe Sensation, Inc. ('Shoe Sensation'), a retailer of branded family footwear in small towns throughout the Midwest. Palisade intends to enhance Shoe Sensation's footprint across the rural Midwest as it grows into a leading niche purveyor of branded footwear and apparel.

On December 3, 2007 Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $2.0 million in Mitralign, Inc. ("Mitralign") as part of a $24.0 million Series C financing round. Mitralign has developed an advanced system for treating mitral valve regurgitation, a heart condition which can lead to damage to the heart and other vital organs of the body. Proceeds from the financing round will enable Mitralign to complete its initial clinical experience and to obtain CE Mark approval of the Mitralign System.

Today Monique Kosse joined Palisade Capital Management as Senior Vice President of Research. Ms. Kosse reports to Jeffrey Schwartz (Palisade's Senior Portfolio Manager) and is responsible for the Healthcare sector in Palisade's Small Cap and Micro-Cap products. Ms. Kosse joins Palisade from Rochdale Investment Management, where she was a Senior Equity Research Analyst. Prior to Rochdale, Ms. Kosse was a Vice President, Healthcare Analyst at Fiduciary Trust Co. and Assistant Healthcare Analyst at Deutsche Asset Management. Ms. Kosse received her M.B.A. in Finance from New York University, Stern School of Business and her B.A. degree from St. Olaf College.

On October 1, 2007, Palisade Concentrated Equity Partnership II, LP ("PCEPII"), a $140 million private equity fund managed by Palisade Capital Management, LLC, invested an additional $1.55 million in Kainos Partners Holding Company, LLC ("Kainos") as part of a $2.3 million financing round, bringing PCEPII's total investment in Kainos to $11.55 million. Kainos will use these additional funds to support its continued roll out of Dunkin' Donuts stores in Buffalo, NY, South Carolina and Las Vegas, NV.

In September 2007, Palisade Concentrated Equity Partnership II, LP ("PCEPII"), a $140 million private equity fund managed by Palisade Capital Management, LLC, converted a $750,000 bridge note dated June 18, 2007 and invested an additional $350,000 in Ikonisys, Inc. ("Ikonisys") as part of a $30.0 million financing round led by a fund controlled by certain Goldman Sachs partners, bringing PCEPII's total investment in Ikonisys to $6.1 million. Since PCEPII's initial investment in Ikonisys in August 2006, Ikonisys has made substantial progress in its development of cell-based diagnostic products for women's health and oncology. The additional capital will enable Ikonisys to fulfill upcoming clinical milestones and further the development and launch of new proprietary tests within its oncoFISH and fastFISH product lines for the diagnosis and management of cancer and for women's health applications.

On June 25, 2007, Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $2.5 million in Word World, LLC ("Word World") with the option to invest an additional $1.25 million through the next financing round. Word World has developed entertainment-based intellectual property targeted at pre-literate children and intends to introduce this concept in 26 half-hour, computer generated, animated television episodes that will begin airing daily on national PBS stations on September 3, 2007. Proceeds from the financing will enable Word World to complete the 26 initial episodes and to continue working towards the design and distribution of Word World licensed products, which will be sold at Target Stores and other retailers beginning in January 2008.

On March 20, 2007, Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $10.0 million in Kainos Partners Holding Company, LLC ("Kainos") as part of a $26.2 million financing round. Kainos has secured agreements with Dunkin' Brands, the franchisor of Dunkin' Donuts restaurants, and intends to open over 150 Dunkin' Donuts franchises in Buffalo, NY, South Carolina and Las Vegas, NV over the next five years.